Caroline Dehais

5PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Jun 01, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.

Patrick R Benusiglio, Fikret Elder, Mehdi Touat

Pageof 1

Frequent Collaborators

5 joint publications

Mehdi Touat

3 joint publications

Ahmed Idbaih

2 joint publications

Franck Bielle

2 joint publications

Diego Prost